Immune dysregulation in cancer patients developing immune-related adverse events.
Khan S, Khan SA, Luo X, Fattah FJ, Saltarski J, Gloria-McCutchen Y, Lu R, Xie Y, Li Q, Wakeland E, Gerber DE.
Khan S, et al. Among authors: lu r.
Br J Cancer. 2019 Jan;120(1):63-68. doi: 10.1038/s41416-018-0155-1. Epub 2018 Oct 31.
Br J Cancer. 2019.
PMID: 30377338
Free PMC article.